A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis | Zendy

Hong Ki Min | Zendy; Jae Ho Lee | Zendy; Hae Min Lee | Zendy; Eun-Sil Koh | Zendy; Ju Yeon Heo | Zendy; Jun-Ki Min | Zendy; Sung Hwan Park | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Case of Acute Myeloid Leukemia after Adalimumab Treatment in Psoriatic Arthritis

Author(s) -

Hong Ki Min,

Jae Ho Lee,

Hae Min Lee,

Eun-Sil Koh,

Ju Yeon Heo,

Jun-Ki Min,

Sung Hwan Park

Publication year - 2012

Publication title -

journal of rheumatic diseases

Language(s) - English

Resource type - Journals

eISSN - 2093-940X

pISSN - 2233-4718

DOI - 10.4078/jrd.2012.19.2.91

Subject(s) - medicine , etanercept , adalimumab , psoriatic arthritis , spondyloarthropathy , myeloid leukemia , infliximab , lymphoproliferative disorders , leukemia , tumor necrosis factor alpha , immunology , arthritis , dermatology , lymphoma

Hematologic malignancies and lymphoproliferative disorders have been reported after using tumor necrosis factor-α inhibitor in patients suffering from spondyloarthropathy. Previously reported cases were treated by using infliximab and etanercept. Usually, it takes approximately several months for leukemia or lymphoproliferative disorders to occur after the application of those agents. However, we report a case of acute myeloid leukemia that developed after short term usage of adalimumab in a patient suffering from psoriatic arthritis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research